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Purpose/objective(s). Long-term quality of life (QoL) impact of side effects per localized prostate cancer treatment has been poorly
documented. The objective was assessing treatments’ QoL impact in localized prostate cancer patients treated with radical
prostatectomy, external beam radiotherapy or brachytherapy, from pre-treatment to seven years after the intervention.
Materials/methods. This is a prospective, observational study of 704 patients recruited in 10 Spanish hospitals (2003–2005), with
follow-upuntil 7-years after treatment. The samplewas composed by consecutive patientswith lowor intermediate risk localized
prostate cancer. The EPIC was administered pre-treatment and annually posttreatment and Generalized Estimating Equation
(GEE) models were constructed to assess impact on Quality of Life.
Results. QoL impact of brachytherapy was presented into the urinary and sexual domains, with GEE coefﬁcients at 7 years indi-
cating worsening of −12.5 points in incontinence, −4.4 in irritative–obstructive, and −7.6 in sexual scores (p<0.001). Compared
to brachytherapy, radical prostatectomy fared −18.9 points worse in incontinence, and −14.2 in sexual scores (p<0.001).
Conclusions. This study provides novel long-term results showing that, despite minor late changes which tend to reduce differ-
ences between treatments, brachytherapy produced the lowest QoL impact (mainly restricted to the urinary domain). Radical
prostatectomy caused considerably greater urinary incontinence and sexual dysfunction, and external radiotherapy greater
bowel impact.
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Objective. To predict late toxicity of radiotherapy in patients who were treated with prostate cancer may be useful to individualize
treatment and to select patients for dose escalation. The aim of this study is to determine if the radiation-induced apoptosis is
useful in patients with prostate cancer.
Methods. Between March 2005 and June 2007 we included in a prospectively study 237 patients, were analyzed with a follow-up
of 8 year for late toxicity. We performed a rapid assay in peripheral blood irradiated with 8Gy before the patient treatment. We
study the grade of radio-induced apoptosis which was quantiﬁed by ﬂow cytometry. Toxicity was deﬁned according to the scale
of the RTOG. We compared the toxicity of patients with the grade of radio-induced apoptosis in CD4 and CD8 T lymphocytes.
Results. The median age was 70 years, 37% were T1c, 33% were T2, 26.6% were T3, and 3.4% were failures, 46% of patients had
Gleason score<7 and 54%≥7. The late GU toxicity was 32%. The overall survival was 95% and the speciﬁc survival was 98%. It
was found a relationship between CD4 T lymphocytes radio-induced apoptosis and late genitourinary (GU) toxicity grade≥1,
this is an inverse relationship, the lower percentage of apoptosis with higher late toxicity. The percentage of patients with a
apoptosis≤30 are more likely to have genitourinary late toxicity (p=0.03). No relationship was found with CD8 T lymphocytes
neither other toxicity.
Conclusions. The rapid assay of radiation-induced lymphocyte apoptosis can predict late GU toxicity in patients with prostate
cancer.
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